Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +35.3% | +24.1% | 2 / 3 | +4.5% | +0.45 pp | +1.29 pp | +25.2% | 0.66 | 5.90 | 364 | +4,5% | 20,6 | +35,3% | 5.90 | 8.90 | −33,7% |
| Pts | 8 | 0 | 8 | 0 | 8 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 44.700 (close price on 2026-10-06)EPS (TTM): 7.576
Financial charts
1.Revenue & growth
VND bn364Q2/26
1.Revenue & growth
VND bn364Q2/26
2.Profit & growth
VND bn20,6Q2/26
3.Profit mix (Penman)
VND bn80,8Q2/26
4.Margins & cost structure
%35.4%Q2/26
5.Returns & cash cycle
% · days20.9%Q2/26
6.Earnings quality & cash
VND bn102Q2/26
7.Asset structure
VND bn711Q2/26
8.Funding & debt health
VND bn · times711Q2/26
9.Revenue backlog
VND bn8,82Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.425Q2/26
Adjusted EPS growth, latest quarter
35.3%
Average adjusted EPS growth, 3 quarters
24.1%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26